Ecopetrol SA EC Listed Among Key Natural Gas Stocks for Energy Transition US Warns Japan of Significant Delays in Tomahawk Missile Deliveries Due to Middle East Stockpiles AI Industry Emerges as Key Beneficiary of HighProfile MuskAltman Legal Proceedings Investors Flock to HALO Stocks A New ETF Captures the AIProof Theme Micron Stock Surges to Record High Following Major PriceTarget Upgrade PayPal Stock Gets Michael Burrys Vote of Confidence But Competitive Pressures Could Keep Trajectory Uneven AMTX Q1 2026 Earnings Earnings Miss and Stock Decline Amidst Operational Challenges GRWG Q1 2026 Earnings NarrowerThanExpected Loss Provides Optimism MGPI Q1 2026 Earnings Massive EPS Beat Amidst Revenue Uncertainty RWTN Q1 2026 Earnings EPS Miss Pared by Positive Surprise but Stock Gains Amid Broader Sector Optimism Ionis Pharmaceuticals Q1 2026 Earnings EPS Beat Driven by Cost Discipline Stock Holds Steady Cactus Inc Q1 2026 Earnings EPS Beats Estimates by 86 as Operational Efficiency Shines Enterprise Financial Services Series A Preferred EFSCP Faces Mild Pullback as Yields Adjust Putnam Municipal Opportunities Trust PMO Edges Higher Amid Stable Income Demand HIVE Digital Technologies HIVE Surges 571 Key Levels to Watch Power Solutions International PSIX Holds Steady Near Support Amid Low Volatility Nkarta Inc NKTX Rallies 345 as Buyers Defend Key Support Level Pentair PNR Holds Steady as Support and Resistance Levels Define Trading Range Raymond James Financial RJF Edges Higher Navigating Support and Resistance Zones Ameris Bancorp ABCB Edges Lower Amid Broader Banking Sector Caution Asbury Automotive Group ABG Edges Higher as Buyers Test Resistance Near 197 Art Technology Acquisition Corp ARTC Holds Steady Near Key Support Level Maxeon Solar Technologies MAXN Holds Steady at 076 Amid Key Technical Levels Perpetua Resources Secures 29 Billion US Loan for Idaho GoldAntimony Project Amid Critical Mineral Push Vaxcyte PCVX Q1 2026 Earnings PreRevenue Biotech Posts WiderThanExpected Loss Stock Gains on Pipeline Confidence OptimizeRx Holds Steady at 494 as Traders Await a Catalyst